In conclusion, our results show that, in addition to CDH1 and CTNNA1 testing in families fulfilling the HDGC criteria, multi-organ cancer predisposition genes should be included in gene panels used for investigating germline variants in patients with diffuse and non-diffuse GC. The gene discussed is CDH1; the disease is cancer.